14-Nov-2024 7:05 AM CST - Business Wire Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the third quarter 2024 and provided a business update. The third quarter has been marked by important advancements on our clinical and corporate fronts. We are poised to comp
14-Nov-2024 7:05 AM CST - Business Wire Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the third quarter 2024 and provided a business update. The third quarter has been marked by important advancements on our clinical and corporate fronts. We are poised to comp
